Ionis' partner Biogen provides update on tofersen Phase 3 VALOR study in SOD1-ALS
Go back to Ionis' partner Biogen provides update on tofersen Phase 3 VALOR study in SOD1-ALS| (NASDAQ: IONS) | Delayed: 45.57 +1.07 (2.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $44.50 | 52 Week High | $62.68 | |||
| Open | $44.56 | 52 Week Low | $19.59 | |||
| Day High | $46.95 | P/E | N/A | |||
| Day Low | $44.06 | EPS | $0.00 | |||
| Volume | 3,742,303 | |||||
